Mini-steroid pills to improve vitiligo surgery results
Part of Skin clinical trials.
This trial tests whether taking small doses of steroids by mouth for a few days before and after a skin cell transplant (NCES) can reduce the white halo that sometimes forms around the treated area. It is for people with stable vitiligo on the face or trunk that hasn't responded to creams or light therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have vitiligo on just one side of your body (segmental) or on your face or trunk (not hands or feet).
- Standard treatments like creams or light therapy haven't worked for you.
- Your vitiligo has been stable (no new spots or growth) for at least 1 year.
- You are 12 years old or older.
- You haven't used any vitiligo treatments (creams or pills) in the last 3 months.
- You are not pregnant, and you do not have uncontrolled high blood pressure, diabetes, or tuberculosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding short bursts of steroid pills to a skin cell transplant procedure can improve results for people with stable vitiligo on hard-to-treat areas like elbows and knees.
This trial tests a surgery that uses your own skin cells to treat stable vitiligo patches. It may help when creams or light therapy haven't worked.
This trial tests a new gel made from stem-cell substances (secretome) given with narrow-band UVB light therapy for stable non-segmental vitiligo. It compares two ways of applying the gel to see which works better.
This study tests whether special particles derived from umbilical cord stem cells can help restore skin color in vitiligo (a condition causing loss of skin pigmentation). The treatment is being tested in adults with vitiligo affecting 1–30% of their body.
This trial tests a new cream for vitiligo on the face or neck. It aims to see if the cream can help bring color back to white patches.
This trial tests whether combining narrowband UVB light with topical steroids can help treat vitiligo, and looks at specific blood markers (CXCL11 and TEMRA) to see how the treatment affects the immune system. It may help patients with stable, non-segmental vitiligo who have not used systemic therapy in the last 3 months.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.